BCI-121
CAS:
Ref. 3D-HSA52982
Informação sobre produto
Nome:BCI-121
Marca:Biosynth
Descrição:BCI-121 is an investigational drug that inhibits the enzyme lysine methyltransferase (KMT), which is involved in the methylation of histones and other cellular proteins. BCI-121 has been shown to inhibit tumor growth and induce tumor cell death by inhibiting mitochondrial functions. The mechanism of action for BCI-121 involves epigenetic regulation of gene expression, meaning that it controls the activity of genes without altering their DNA sequence. In cancer cells, BCI-121 inhibits the synthesis of DNA, RNA, and protein, leading to apoptosis. This drug also shows potential for treating inflammatory diseases such as rheumatoid arthritis by inhibiting KMT activity in immune cells.
Aviso:Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Propriedades químicas
Peso molecular:340.22 g/mol
Fórmula:C14H18BrN3O2
Pureza:Min. 95%